Get the Stockscreener App
1.64
5.20%
-0.09
After Hours:
1.64
China Pharma Holdings Inc. stock is traded at $1.64, with a volume of 7,623.
It is down -5.20% in the last 24 hours and down -15.90% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.73
Open:
$1.67
24h Volume:
7,623
Relative Volume:
0.16
Market Cap:
$5.35M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-4.881
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-9.69%
1M Performance:
-15.90%
6M Performance:
-23.72%
1Y Performance:
-36.56%
1-Day Range:
$1.64
$1.69
1-Week Range:
$1.64
$1.85
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.64 | 5.64M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Can China Pharma Holdings Inc. (XQJ0) stock expand revenue streams2025 Volatility Report & Community Shared Stock Ideas - newser.com
Will China Pharma Holdings Inc. stock outperform value peersFed Meeting & Weekly High Return Stock Forecasts - newser.com
Can China Pharma Holdings Inc. stock withstand sector downturnsMarket Trend Report & Stock Portfolio Risk Control - newser.com
Why China Pharma Holdings Inc. is moving todayJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
What catalysts could drive China Pharma Holdings Inc. stock higherDollar Strength & Long-Term Growth Portfolio Plans - newser.com
Is China Pharma Holdings Inc. stock a buy for dividend portfoliosQuarterly Profit Review & Technical Pattern Recognition Alerts - newser.com
Pattern recognition hints at China Pharma Holdings Inc. upsideTrade Volume Summary & Technical Pattern Based Signals - newser.com
Has China Pharma Holdings Inc. formed a bullish divergence2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Is China Pharma Holdings Inc. (XQJ0) stock safe for risk averse investorsLong Setup & Real-Time Chart Breakout Alerts - newser.com
Why analysts raise outlook for China Pharma Holdings Inc. stockJuly 2025 Patterns & Stock Market Timing Techniques - newser.com
Can China Pharma Holdings Inc. stock surprise markets with earningsWeekly Gains Report & Community Consensus Trade Alerts - newser.com
What high frequency data says about China Pharma Holdings Inc.Quarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Will China Pharma Holdings Inc. (XQJ0) stock outperform foreign stocks2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
What machine learning models say about China Pharma Holdings Inc.July 2025 Momentum & Entry and Exit Point Strategies - newser.com
Key resistance and support levels for China Pharma Holdings Inc.Trade Entry Summary & Low Risk Entry Point Tips - newser.com
Will China Pharma Holdings Inc. (XQJ0) stock sustain bullish trend into 2025July 2025 Levels & Reliable Momentum Entry Alerts - newser.com
Using AI based signals to follow China Pharma Holdings Inc.Portfolio Return Report & Fast Gain Swing Trade Alerts - newser.com
Does China Pharma Holdings Inc. qualify in momentum factor screening2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
Does China Pharma Holdings Inc. stock trade below intrinsic valueWeekly Investment Report & Fast Entry Momentum Alerts - newser.com
Will China Pharma Holdings Inc. stock gain from lower inflationBull Run & Daily Risk Controlled Trade Plans - newser.com
Is China Pharma Holdings Inc. trending in predictive chart modelsJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Published on: 2025-10-30 06:02:29 - newser.com
How China Pharma Holdings Inc. stock trades during market volatilityQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com
Can China Pharma Holdings Inc. (XQJ0) stock surprise markets with earnings2025 Pullback Review & AI Driven Price Forecasts - newser.com
Is Quint Digital Limiteds Business Model Sustainable Long TermCapital Gains Strategies & Low Cost Portfolio Ideas - earlytimes.in
What technical patterns form on China Pharma Holdings Inc. (XQJ0) stock chartsEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
How to monitor China Pharma Holdings Inc. with trend dashboardsGlobal Markets & Risk Managed Investment Signals - newser.com
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):